[go: up one dir, main page]

MX2017011198A - Biomarcadores para preeclampsia. - Google Patents

Biomarcadores para preeclampsia.

Info

Publication number
MX2017011198A
MX2017011198A MX2017011198A MX2017011198A MX2017011198A MX 2017011198 A MX2017011198 A MX 2017011198A MX 2017011198 A MX2017011198 A MX 2017011198A MX 2017011198 A MX2017011198 A MX 2017011198A MX 2017011198 A MX2017011198 A MX 2017011198A
Authority
MX
Mexico
Prior art keywords
preeclampsia
biomarkers
hemopexin
microglobulin
markers
Prior art date
Application number
MX2017011198A
Other languages
English (en)
Inventor
Göran Gram Magnus
Hansson Stefan
Åkerström Bo
Original Assignee
A1M Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A1M Pharma Ab filed Critical A1M Pharma Ab
Publication of MX2017011198A publication Critical patent/MX2017011198A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4713—Plasma globulins, lactoglobulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere al uso de hemopexina, hemoglobina fetal no unida a las células, libre y alfa-1-microglobulina como marcadores para preeclampsia.
MX2017011198A 2015-03-16 2016-03-16 Biomarcadores para preeclampsia. MX2017011198A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201570146 2015-03-16
DKPA201570794 2015-12-03
PCT/EP2016/055619 WO2016146647A1 (en) 2015-03-16 2016-03-16 Biomarkers for preeclampsia

Publications (1)

Publication Number Publication Date
MX2017011198A true MX2017011198A (es) 2018-02-19

Family

ID=55586291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011198A MX2017011198A (es) 2015-03-16 2016-03-16 Biomarcadores para preeclampsia.

Country Status (14)

Country Link
US (1) US20180074070A1 (es)
EP (1) EP3271727A1 (es)
JP (1) JP2016173366A (es)
KR (1) KR20170125975A (es)
CN (1) CN107430134A (es)
AU (1) AU2016232309A1 (es)
BR (1) BR112017018436A2 (es)
CA (1) CA2977458A1 (es)
EA (1) EA201791978A1 (es)
MX (1) MX2017011198A (es)
SG (1) SG11201706736RA (es)
TW (1) TW201702383A (es)
WO (1) WO2016146647A1 (es)
ZA (1) ZA201705532B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108776226B (zh) * 2018-04-08 2021-03-19 邓成 晚发型子痫前期快速筛查用试纸和试剂盒
EP3813847A4 (en) * 2018-06-28 2022-04-06 Salaqua Diagnostics, Inc. COMPOSITIONS AND METHODS RELATING TO A HAPTOGLOBIN ASSOCIATED PROTEIN
CN109867717A (zh) * 2019-04-01 2019-06-11 山西瑞亚力生物技术有限公司 一种血浆中α1微球蛋白的提取方法
CN113495149A (zh) * 2020-03-19 2021-10-12 首都医科大学附属北京世纪坛医院 尿液α1-微球蛋白及其多肽片段在妊娠糖尿病中的应用
US20240101640A1 (en) * 2020-08-21 2024-03-28 Csl Behring Ag Cd91 polypeptide for use in detecting hemopexin:heme complex
AU2021418225A1 (en) * 2021-01-05 2023-07-13 Public University Corporation Yokohama City University Biomarker for determining fertility, and determining method using same
CN113092777B (zh) * 2021-03-26 2023-11-14 泰达国际心血管病医院 孕早期进行重症子痫前期患者筛查的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2614832T3 (pl) 2007-02-12 2017-01-31 A1M Pharma Ab Diagnostyka i leczenie stanu przedrzucawkowego
HRP20150802T1 (xx) 2010-03-24 2015-11-06 Preelumina Diagnostics Ab Hbf i a1m kao markeri za rano otkrivanje preeklampsije
HK1206790A1 (en) * 2012-05-08 2016-01-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for providing a preeclampsia assessment
WO2014143977A2 (en) * 2013-03-15 2014-09-18 Sera Prognostics, Inc. Biomarkers and methods for predicting preeclampsia

Also Published As

Publication number Publication date
CN107430134A (zh) 2017-12-01
EA201791978A1 (ru) 2018-01-31
WO2016146647A1 (en) 2016-09-22
TW201702383A (zh) 2017-01-16
CA2977458A1 (en) 2016-09-22
AU2016232309A1 (en) 2017-09-28
BR112017018436A2 (pt) 2018-04-17
EP3271727A1 (en) 2018-01-24
US20180074070A1 (en) 2018-03-15
ZA201705532B (en) 2020-01-29
JP2016173366A (ja) 2016-09-29
KR20170125975A (ko) 2017-11-15
SG11201706736RA (en) 2017-09-28

Similar Documents

Publication Publication Date Title
PH12018501159A1 (en) Composition and methods for immunooncology
PH12016501763B1 (en) Multispecific antibodies
PH12017502180A1 (en) Tau-binding antibodies
MX2017011198A (es) Biomarcadores para preeclampsia.
GT201700284A (es) Terapias de combinación para enfermedades malignas hematológicas con anticuerpos anti-cd38 e inhibidores de survivina
PH12018500906A1 (en) Antibodies specifically binding pd-1 and their uses
MX2021008376A (es) Cultivo, produccion, procesamiento y uso de cannabis de especialidad.
TWD187330S (zh) 汽車
PH12017502207B1 (en) Tau-binding antibodies
PH12015501071A1 (en) Combination therapy of anti-her3 antibodies
FI20155280A7 (fi) Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
MX354303B (es) Anticuerpos de anti-biotina y metodos de uso.
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
MX2016014416A (es) Anticuerpos anti-her3 que se unen a la horquilla beta de her3.
MX2018004005A (es) Ensayo de potencia celular.
MY187959A (en) Reactor
WO2015107430A3 (en) Methods and biomarkers for detection and prognosis of cervical cancer
IL268770A (en) Aptamer as a biomarker
MX2015009161A (es) Polioles, su preparación y su uso.
MY199933A (en) Compositions and methods for immunooncology
MX2016016577A (es) Aleacion de fundicion de aluminio.
IN2013CH00453A (es)
AU345983S (en) Cosmetic cases and cosmetic kits
AU348634S (en) Bus